Companion Animal Diagnostics Market By animal Type (Horses, Dogs, Cats, Other Companion Animals), By Application (Clinical Pathology, Virology, Bacteriology, Parasitology and Other), By Technology (Molecular Diagnostics Urinalysis, Hematology, Immunodiagnostics, Clinical Biochemistry), By End User (Research Institutes and Universities, Veterinary Reference Laboratories, Veterinary Hospitals, and Clinics), By Geography (North America, Europe, Asia Pacific, Rest of the World Forecast up to 2026

  • August, 2020
  • Domain: Healthcare - Diagnostics
Pages: 128
Tables: 85
Charts: 125
Regions/Countries: 4/9
Companies: 20
Enquiry Hours: 10
  • Get Free 10% Customization in this Report

The companion animal diagnostics market provides crucial insights for the development of a treatment regimen that enhances the quality of overall animal healthcare. Animal diagnostics is a high-tech market with various companies offering advanced molecular testing products. Furthermore, the rising demand for fully automated and semi-automated diagnostic tests is anticipated to further spur the demand for companion animal diagnostics. Automatic testing tools will result in efficient handling of large volumes of samples and increased productivity, whereas the tests are cost-effective and cover a wide range of diseases. The growth of companion animal diagnostics is projected to propel in the future by the emerging use of micro fluids and miniaturization, among others supported commercialization and development of Vitro diagnostic devices and imaging systems.

Companion Animal Diagnostics Market

The purview of the Companion Animal Diagnostics Market is defined in the market analysis as follows:

  • Animal Type: Market Size & Analysis
    • Horses          
    • Dogs  
    • Cats   
    • Other Companion Animals            

Based on animal type, the market is segmented into horses, dogs, cats, and other animals. Among them, dogs accounted for the largest market share in 2019, which was the result of the increasing incidence of obesity, diabetes, cancer, and other major diseases among dogs. According to the Association for Pet Obesity Prevention (APOP) report, 56% of dogs were recorded as obese in the U.S. in 2019. Obesity increases the possibility of joint problems, cancer, diabetes, and other chronic conditions. Increasing animal healthcare expenditure, especially in the developed regions, is propelling the growth. The rise in awareness among pet owners has resulted in a frequent diagnosis of glucose levels, thus increasing the demand for glucose monitors.

Research Methodology:

The companion animal diagnostics market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology, along with an irreplaceable blend of primary insights. The real-time assessment of the market is an integral part of our market sizing and forecasting methodology. Our industry experts and panel of primary participants have helped in compiling relevant aspects with realistic parametric estimations for a comprehensive study. The participation share of different categories of primary participants is given below:

Global Companion Animal Diagnostics Market

  • Application: Market Size & Analysis
    • Clinical Pathology
    • Virology        
    • Bacteriology
    • Parasitology
    • Other

The application market is categorized into clinical pathology, bacteriology, virology, parasitology, and other applications, owing to the growing volume of various pathology tests performed in pets. Clinical pathology is further divided into cytopathology, clinical chemistry, endocrinology, coagulation, hematology, immunohematology, urinalysis, and general pathology. The clinical pathology tests are taken as the first tool for the assessment of disease patterns as it gives an understanding of disease mechanism and progression, which is crucial for the development of new treatments. The growing concern among pet owners about pet health is a key factor propelling the demand for innovative diagnostic products.

  •  Technology: Market Size & Analysis
    • Molecular Diagnostics       
    • Polymer Chain Reaction Tests    
    • Microarrays 
    • Other Molecular Diagnostic Products   
    • Urinalysis     
    • Urinalysis Clips & Cartridges       
    • Urine Analyzers      
    • Urine Test Strips    
    • Hematology
    • Hematology Cartridges     
    • Hematology Analyzers      
    • Immunodiagnostics           
    • Clinical Biochemistry        

Amidst these segments, the molecular diagnostics technology is assumed to have a major share in the market. The need for authentic, specific, and quick methods to identify chronic diseases and genetic disorders in the early stages is expected to boost the molecular diagnostics market for companion animal diagnostics.

  • Based on End-User
    • Research Institutes and Universities
    • Veterinary Reference Laboratories
    • Veterinary Hospitals and Clinics
  • Based on Geography:
    • North America
    • Europe
    • Asia Pacific
    • Rest of the World

Globally the animal diagnostics market is divided into five major regions, namely, North America, Europe, the Asia Pacific, and Rest of the World. In 2019, North America was estimated to share the largest regional market for companion animal diagnostics. Somehow, the Asia Pacific market is projected to grow at the highest CAGR in the forecast period because of factors such as rise in pet adoption, increased awareness about animal health, and dramatically increasing per capita animal health expenditure, specifically in India and China.

The Companion Animal Diagnostics Market is growing at a CAGR of 8.82% during the forecast period of 2020-2026. The factors enhancing this market growth are cost-beneficial service, approachable software to everyone in the business for providing valuable solutions for the firm.

The report also includes the analysis of major players in the Companion Animal Diagnostics market. Some of the major players consist of IDvet, Randox Laboratories, Ltd, Mindray Medical International Limited, Skyla, Bionote Inc, Scil Animal Care Company GmbH, Unit Medical Electronic Co., Ltd, Eurolyser Diagnostica GmbH, Nova Biomedical, and Fassisi GmbH.

This report will help the market players to analyze the key market trends, market dynamics, and dynamic needs of the end-users. The qualitative and quantitative analysis will provide deep insights into the user experience of the report. 

  • The competitive analysis of the major players in the market gives the freedom to the users to understand the dynamic strategies such as product innovation, partnerships, merger & acquisitions and joint ventures of the key players.
  • This report also provides the insights of leading players in various types of analysis like SWOT analysis, portfolio analysis, capability analysis of the leading players.
  • The quantitative and exhaustive analysis of the market enables users to understand the facts of the market across four major regions.

1. Executive Summary

2. Industry Outlook

2.1. Industry Overview

2.2. Industry Trends

3. Market Snapshot

3.1. Market Definition

3.2. Market Outlook

3.3. PEST Analysis

3.4. Porter Five Forces

3.5. Related Markets

4. Market characteristics

4.1. Market Evolution

4.2. Market Trends and Impact

4.3. Advantages/Disadvantages of Market

4.4. Regulatory Impact

4.5. Market Offerings

4.6. Market Segmentation

4.7. Market Dynamics

4.7.1. Drivers

4.7.2. Restraints

4.7.3. Opportunities

4.8. DRO - Impact Analysis

5. End User: Market Size & Analysis

5.1. Overview     

5.2. Research Institutes and Universities             

5.3. Veterinary Reference Laboratories    

5.4. Veterinary Hospitals and Clinics        

6. Animal Type: Market Size & Analysis

6.1. Overview

6.2. Horses         

6.3. Dogs           

6.4. Cats            

6.5. Other Companion Animals               

7. Application: Market Size & Analysis

7.1. Overview

7.2. Clinical Pathology

7.3. Bacteriology

7.4. Virology

7.5. Parasitology

7.6. Other          

8. Technology: Market Size & Analysis

8.1. Overview

8.2. Molecular Diagnostics           

8.2.1. Polymer Chain Reaction Tests         

8.2.2. Microarrays

8.2.3. Other Molecular Diagnostic Products           

8.3. Urinalysis    

8.3.1. Urinalysis Clips & Cartridges           

8.3.2. Urine Analyzers      

8.3.3. Urine Test Strips    

8.4. Hematology             

8.4.1. Hematology Cartridges       

8.4.2. Hematology Analyzers        

8.5. Immunodiagnostics             

8.6. Clinical Biochemistry            

9. Geography: Market Size & Analysis

9.1. Overview

9.2. North America

9.3. Europe

9.4. Asia Pacific

9.5. Rest of the World

10. Competitive Landscape

10.1. Competitor Comparison Analysis

10.2. Market Developments

10.3. Mergers and Acquisitions, Legal, Awards, Partnerships

10.4. Product Launches and execution

11. Vendor Profiles

11.1. IDvet

11.1.1. Overview

11.1.2. Product Offerings

11.1.3. Geographic Revenue

11.1.4. Business Units

11.1.5. Developments

11.1.6. Business Strategy

11.2. Randox Laboratories, Ltd

11.2.1. Overview

11.2.2. Product Offerings

11.2.3. Geographic Revenue

11.2.4. Business Units

11.2.5. Developments

11.2.6. Business Strategy

11.3. Mindray Medical International Limited

11.3.1. Overview

11.3.2. Product Offerings

11.3.3. Geographic Revenue

11.3.4. Business Units

11.3.5. Developments

11.3.6. Business Strategy

11.4. Skyla

11.4.1. Overview

11.4.2. Product Offerings

11.4.3. Geographic Revenue

11.4.4. Business Units

11.4.5. Developments

11.4.6. Business Strategy

11.5. Bionote Inc

11.5.1. Overview

11.5.2. Product Offerings

11.5.3. Geographic Revenue

11.5.4. Business Units

11.5.5. Developments

11.5.6. Business Strategy

11.6. Scil Animal Care Company GmbH.

11.6.1. Overview

11.6.2. Product Offerings

11.6.3. Geographic Revenue

11.6.4. Business Units

11.6.5. Developments

11.6.6. Business Strategy

11.7. Urit Medical Electronic Co., Ltd

11.7.1. Overview

11.7.2. Product Offerings

11.7.3. Geographic Revenue

11.7.4. Business Units

11.7.5. Developments

11.7.6. Business Strategy

11.8. Eurolyser Diagnostica GmbH

11.8.1. Overview

11.8.2. Product Offerings

11.8.3. Geographic Revenue

11.8.4. Business Units

11.8.5. Developments

11.8.6. Business Strategy

11.9. Nova Biomedical

11.9.1. Overview

11.9.2. Product Offerings

11.9.3. Geographic Revenue

11.9.4. Business Units

11.9.5. Developments

11.9.6. Business Strategy

11.10. Fassisi GmbH

11.10.1. Overview

11.10.2. Product Offerings

11.10.3. Geographic Revenue

11.10.4. Business Units

11.10.5. Developments

11.10.6. Business Strategy

12. Companies to Watch

12.1. Swissavans AG

12.1.1. Overview

12.1.2. Market

12.1.3. Business Strategy

12.2. IDEXX Laboratories, Inc

12.2.1. Overview

12.2.2. Market

12.2.3. Business Strategy

12.3. Zoetis Inc

12.3.1. Overview

12.3.2. Market

12.3.3. Business Strategy

12.4. Heska Corporation

12.4.1. Overview

12.4.2. Market

12.4.3. Business Strategy

12.5. Thermo Fisher Scientific Inc

12.5.1. Overview

12.5.2. Market

12.5.3. Business Strategy

12.6. Virbac

12.6.1. Overview

12.6.2. Market

12.6.3. Business Strategy

12.7. Neogen Corporation

12.7.1. Overview

12.7.2. Market

12.7.3. Business Strategy

12.8. Biomérieux SA

12.8.1. Overview

12.8.2. Market

12.8.3. Business Strategy

12.9. INDICAL Bioscience GmbH

12.9.1. Overview

12.9.2. Market

12.9.3. Business Strategy  

12.10. Fujifilm Holdings Corporation

12.10.1. Overview

12.10.2. Market

12.10.3. Business Strategy

13. Analyst Opinion

14. Annexure

14.1. Report Scope

14.2. Market Definitions

14.3. Research Methodology

14.3.1. Data Collation and In-house Estimation

14.3.2. Market Triangulation

14.3.3. Forecasting

14.4. Report Assumptions

14.5. Declarations

14.6. Stakeholders

14.7. Abbreviations

 

Research Framework

Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting

Market related information is congregated from both primary and secondary sources.

Primary sources

involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources

include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

Interested in this report?
Get your FREE sample now!

Select User License

$

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer 10% worth of FREE customization at the time of purchase